Gottfried Von Keudell, Md Phd

This study tests a drug called odronextamab in 35 people with untreated, low-tumor follicular lymphoma. The goal is to see if it can shrink or eliminate cancer without needing standard chemotherapy. Participants receive the drug and are monitored for safety and response.

This study tests a drug called epcoritamab in 20 people with Waldenstrom macroglobulinemia, a rare blood cancer, that has already been treated. The drug is a type of antibody that helps the immune system attack cancer cells. The main goal is to see how many patients respond to th…

This study tests whether combining two drugs, rituximab and venetoclax, can shrink or eliminate tumors in people with untreated marginal zone lymphoma. About 33 participants will receive the treatment to see how many achieve complete remission. The goal is to find a more effectiv…